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Oligodendrocyte myelin glycoprotein (OMgp) is expressed by both neurons and oligodendrocytes in the CNS. It has been implicated in
growth cone collapse andneurite outgrowth inhibitionby signaling through theNogo receptor andpaired Ig-like receptorB (PirB).OMgp
was also reported to be an extracellular matrix (ECM) protein surrounding CNS nodes of Ranvier and proposed to function as (1) an
inhibitor of nodal collateral sprouting and (2) an important contributor to proper nodal and paranodal architecture. However, we show
here that the anti-OMgp antiserum used in previous studies to define the functions of OMgp at nodes is not specific. Among all reported
nodal ECMcomponents, the antiserumexhibited strong cross-reactivity against versicanV2 isoform, a chondroitin sulfate proteoglycan.
Furthermore, the OMgp antiserum labeled OMgp-null nodes, but not nodes from versican V2-deficient mice, and preadsorption of the
OMgp antiserum with recombinant versican V2 blocked nodal labeling. Analysis of CNS nodes in OMgp-null mice failed to reveal any
nodal or paranodal defects, or increased nodal collateral sprouting, indicating that OMgp does not participate in CNS node of Ranvier
assembly or maintenance. We successfully identified a highly specific anti-OMgp antibody and observed OMgp staining in white matter
only after initiation of myelination. OMgp immunoreactivity decorated the surface of mature myelinated axons, but was excluded from
compact myelin and nodes. Together, our results strongly argue against the nodal localization of OMgp and its proposed functions at
nodes, and reveal OMgp’s authentic localization relative to nodes and myelin.
Introduction
Nodes of Ranvier are highly enriched in ion channels that play
essential roles in saltatory conduction. Specific cell adhesionmol-
ecules and cytoskeletal scaffolds are also clustered at nodes and
establish and/ormaintain the proper function and architecture of
nodes (Poliak and Peles, 2003; Salzer, 2003; Susuki and Rasband,
2008). In addition, a specialized ECM is assembled aroundnodes.
By immunostaining, several CNS nodal ECM components have
been identified: three chondroitin sulfate proteoglycans (brevican,
phosphacan, and versican V2), brain link protein 1, tenascin-R,
and OMgp (Bartsch et al., 1993; Xiao et al., 1997; Oohashi et al.,
2002;Huang et al., 2005;Hedstrom et al., 2007). CNS nodal ECM
components have been proposed to (1) contribute to the extra-
cellular pool of sodium ions in the perinodal space, (2) inhibit
axonal sprouting at nodes, and (3) contribute to node formation
(Kaplan et al., 1997; Oohashi et al., 2002; Huang et al., 2005;
Susuki and Rasband, 2008; Bekku et al., 2010).
Among the nodal ECM components, OMgp is a Nogo recep-
tor and PirB ligand, and their interactions mediate neurite out-
growth inhibition (Vourc’h and Andres, 2004; Atwal et al., 2008;
Giger et al., 2008). OMgp was first identified and purified from
human CNS white matter by its peanut agglutinin (PNA)-
binding property (Mikol and Stefansson, 1988). Although it can
be a glycosylphosphatidylinositol (GPI)-anchored protein,OMgp is
also found without its GPI moiety in brain homogenates and
oligodendrocyte-conditioned medium (Mikol and Stefansson,
1988; Nie et al., 2006), suggesting that OMgp can be released
from the cell surface. OMgp localization was first described in
human CNS myelin and on the surface of cultured ovine oligo-
dendrocytes (Mikol and Stefansson, 1988). Later studies using a
rabbit anti-humanOMgp antiserum reportedOMgp localization
in the outer edges of PNS myelin sheaths around the paranodes
(Apostolski et al., 1994), and at both PNS and CNS nodes of
Ranvier (Huang et al., 2005; Nie et al., 2006).
OMgp-null mice were reported to show strain-specific im-
provements in axon regeneration (Ji et al., 2008), more frequent
axonal sprouting at nodes, disturbed paranodes, and wider nodal
gaps (Huang et al., 2005).
Given the proposed role for OMgp in CNS node of Ranvier
function and assembly, we sought to determine the molecular
mechanisms whereby OMgp performs its functions. However,
we found the rabbit anti-OMgp antiserumused in previous stud-
ies showing nodal localization (Huang et al., 2005; Nie et al.,
2006) is not specific to OMgp. Instead, it cross-reacts with versi-
canV2,which is responsible for the nodal staining. Immunostain-
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ing with a specific anti-OMgp antibody pinpointed OMgp around
compact myelin, but not at nodes. Our analysis of OMgp-null
mice showed normal paranodal junctions and nodal architec-
ture. Therefore, OMgp is not accumulated at the nodal ECM and
does not play the essential role in node formation and stabiliza-
tion as previously proposed (Huang et al., 2005; Nie et al., 2006).
Materials andMethods
Animals.OMgp-null mice were generously provided by Dr. ShaMi (De-
partment of Discovery Biology, Biogen Idec) (Ji et al., 2008). Versican V0/
V2-null mice were described previously (Dours-Zimmermann et al., 2009).
Wild-type ICR and C57BL/6mice were purchased fromCharles River.
Antibodies. The following primary antibodies were used: rabbit anti-
OMgp antiserum, kindly provided by Dr. Amyn Habib (Department of
Neurology, University of Texas Southwestern Medical Center, Dallas, TX)
(-OMgp*) (Habib et al., 1998; Huang et al., 2005; Nie et al., 2006);
mouse anti-OMgp monoclonal clone 1A8 (H00004974-M06, Abnova);
rabbit Prestige anti-OMgp (HPA012693, Sigma); goat anti-OMgp
(AF1674, R&D Systems); mouse anti-Kv1.2 (K14/16, UC Davis/NIH
NeuroMab Facility); chicken anti-IV spectrin antibody, generated and
affinity purified against the same peptide as previously reported for the rab-
bit anti-IV spectrin SD antibody (Berghs et al., 2000); rabbit anti-versican
V0/V2 (Dours-Zimmermann et al., 2009); mouse anti-Caspr (K65/35,
NeuroMab); mouse anti-myelin basic protein (MBP) (Covance); and
rabbit anti-neurofilament M (Millipore). Horseradish peroxidase
(HRP)-conjugated goat anti-human Fc was from Jackson Immu-
noResearch Laboratories. HRP-conjugated donkey anti-goat IgG, goat
anti-rabbit IgG, and goat anti-mouse IgG were fromMP Biomedicals.
Fluorescent dye-conjugated secondary antibodies were purchased
from Invitrogen.
Fc fusion proteins. The cDNAs corresponding
to mouse OMgp (amino acids 25–417,
NP_062282.1), rat brevican (amino acids 25–
883, AAA87847.1), and human versican V2
(amino acids 21–1642, AAA67565.1) were
cloned into pSX-Fc (Eshed et al., 2007) in frame
to the signal peptide and human IgG1 Fc. The
pSX-Fc plasmid was kindly provided by Drs. E.
Peles and Y. Eshed (Weizmann Institute of Sci-
ence, Rehovot, Israel). The Fc fusion DNA con-
structs were transfected into COS-7 cells with
Lipofectamine 2000 (Invitrogen) according to
themanufacturer’s instructions. Themedia were
changed to VP-SFM (Invitrogen) containing 2
GlutaMAX-I. The media containing Fc fusions
were harvested by centrifuging at 3000 g for 3
min and collecting the supernatants.
Immunostaining. Immunostaining of optic
and sciatic nerves and spinal cords was per-
formed as described previously (Rasband et al.,
1999; Schafer et al., 2004). For analysis of node
organization, the gap distance between a pair
of Caspr-labeled paranodes and the width of
Caspr staining weremeasured with AxioVision
(Carl Zeiss) as the nodal length and axon diam-
eter, respectively (wild-type, n  423; OMgp-
null, n  423). Statistical analysis was
performed using the Student’s t test, and errors
indicated areSEM.
Dot blotting and Western blotting. Brain
membrane homogenates were prepared as de-
scribed previously (Schafer et al., 2004). The
brain cytosolic fractions were the supernatants
collected after the second centrifugation step.
Nerve extracts were prepared by collecting su-
pernatants from nerves sonicated in homoge-
nizing buffer on ice, and centrifuged at 600 g
for 10 min. Immunoblotting was performed as
described previously (Schafer et al., 2004). Be-
fore electrophoresis, chondroitin sulfate digestion of brain membrane
homogenates and cytosolic fractions was performed by incubating sam-
ples in 50 mM Tris-HCl, pH 8.3, 60 mM sodium acetate, pH 8, 10 mM
EDTA, 0.02% BSA (w/v), and 0.4–0.67 U/ml chondroitinase ABC
(Sigma) at 37°C for 16 h.
Immunoadsorption. Fc fusion proteins in the collected media were
applied to nitrocellulose membranes by dot blot. The regions of the
membrane with Fc fusion proteins were cut, put in 1.5 ml microcentri-
fuge tubes, and washed with 0.1 M phosphate buffer, pH 7.4, containing
0.3%Triton X-100 and 10% goat serum (PBTGS). The primary antibod-
ies diluted in PBTGS were incubated with the membrane in the tubes at
4°C overnight and then applied to tissue sections for immunostaining.
Rotarod.Mice were conditioned on the rotating rod (Ugo Basile) at 4
rpm for 5 min. Mice then received a 1 h break. Mice were then tested for
latency to fall in three trials by placing them on the rotating rod, which
accelerated from 4 to 40 rpm in 5 min. Each trial was separated by a 30
min break, and latencies to fall were averaged across all trials.
Electron microscopy. One-hundred-day-old wild-type (WT) (n  3)
and OMgp knock-out (n 3) mice were anesthetized with ketamine (80
mg/kg) and xylazine (16 mg/kg) by intraperitoneal injection. Then the
animals were perfused with 2.5% glutaraldehyde and 2.0% paraformal-
dehyde in 0.1 M cacodylate buffer, pH 7.4. Optic nerves were dissected
out and postfixed in the same fixative for an additional 3 h. Then, the
nerves were postfixed in 1% osmium tetroxide solution in 0.1 M cacody-
late buffer, pH 7.4, for 2 h. After washing, nerves were dehydrated
through a graded ethanol series and embedded in low-viscosity resin
(Electron Microscopy Sciences). Tissues were en bloc stained for 1 h in
saturated uranyl acetate plus 50% ethanol during dehydration. The sec-
tioning and electron microscopy was performed in the Baylor College of
Medicine Integrated Microscopy Core (Director: Dr. Michael A. Mancini).
Figure 1. -OMgp* is not specific to OMgp and cross-reacts with versican V2.A, Spinal cord sections fromwild-type and OMgp-null
mice immunostainedwith-OMgp* (green), anti-IV spectrin (blue), and anti-Kv1.2 (red). Arrowheads indicate nodes of Ranvier. Scale
bars,10m.B,MediacollectedfromCOS-7cellculturesexpressingpalmitoylatedEGFP(GFP),Fc,OMgp-Fc,brevican-Fc,andversicanV2-Fc
were applied to nitrocellulose membranes onefold (1) or twofold (2) concentrated and probed with-OMgp* or anti-human Fc.
C, Immunoblotting of brainmembrane homogenates (hom; 75g) and cytosolic fractions (sup; 20g)made fromWT, OMgp-null, and
versican V0/V2-null brains with or without chondroitinase ABC treatment (Ch’ase/). Blots were probed with -OMgp* or anti-
versicanV2antibodies. Thetoparrowhead indicates thepositionofversicanV2,andthebottomtwoopenarrowheads indicateOMgpwith
(upper) andwithout (lower) theGPImoiety (Mikol and Stefansson, 1988).
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Longitudinal and transverse thin sections of70 nm were obtained us-
ing an RMC MT6000-XL ultramicrotome and a Diatome Ultra45 dia-
mond knife, and collected on 150 hex-mesh copper grids. The dried
sections were counterstained with Reynold’s lead citrate for 4 min after
microtomy. Sections were observed using a transmission electronmicro-
scope (H7500, Hitachi). Images were obtained and measurements were
performed using a Gatan US1000 digital camera and Digital Micrograph
v1.82.366 software.
Results
Rabbit anti-OMgp antiserum labels CNS nodes in OMgp-null
mice and cross-reacts with versican V2
While investigating the functional role of OMgp in the CNS nodal
ECM, we unexpectedly found that the rabbit anti-human OMgp
antiserum(referred tohereafter as-OMgp*)used inprevious stud-
ies (Huang et al., 2005;Nie et al., 2006) stained strongly the nodes of
Ranvier inbothwild-type andOMgp-null spinal cords (Fig. 1A) and
optic nerves (Fig. 2A,B). Thus, the nodal signal by this antiserum
cannot be solely attributed to OMgp.
To determine whether this antiserum cross-reacts with other
nodal ECM components such as versican V2 and/or brevican, we
generated recombinant OMgp-Fc, versican V2-Fc, and brevican-Fc
fusion proteins inCOS-7 cells. These fusion proteinswere subjected
to immunoblotting using -OMgp*. As shown in Figure 1B, al-
though -OMgp* detected OMgp-Fc, versican V2-Fc was detected
muchmore strongly.
To further confirm the cross-reactivity against versican, we ana-
lyzed brain homogenates from wild-type, OMgp-null, and versican
V0/V2-null mice. -OMgp* detected not only OMgp in the brain
membrane homogenates prepared from the wild-type and versican
V0/V2-null brains (Fig. 1C), but also versican V2 in the membrane
homogenates and cytosolic fractions from wild-type and OMgp-
null preparations (Fig. 1C). The extracellular versican in the mem-
brane homogenates ismodifiedwith chondroitin sulfate side chains
(Yamaguchi, 2000; Zimmermann andDours-Zimmermann, 2008),
and removal of these side chains is required for the bulk of versican
to enter the SDS-PAGE gels (Schmalfeldt et al., 1998) (Fig. 1C). At
the mobility similar to that of versican V2, only weak background
signals that were insensitive to chondroitin sulfate digestion were
detected in the versicanV0/V2-null preparations by-OMgp* (Fig.
1C). These observations indicate that the-OMgp* antiserumused
in the previous studies is not specific to OMgp, but instead strongly
cross-reacts with versican V2.
-OMgp* antiserum detects versican V2 at CNS nodes
of Ranvier
To test whether the nodal -OMgp* staining is due to its cross-
reactivity with versican V2, we immunostained versican V0/V2-
null tissues. We found that -OMgp* labeled wild-type and
OMgp-null nodes (Fig. 2A,B), but no staining was observed at
versican V0/V2-null nodes (Fig. 2C), strongly suggesting that
versican V2, but not OMgp, is detected by -OMgp* at CNS
nodes.Toexclude thepossibility that thepresenceofOMgpatnodes
requires versican V2, we stained the wild-type spinal cord with
-OMgp* preadsorbed with OMgp-Fc or versican V2-Fc. While
-OMgp* preadsorbed with OMgp-Fc still labeled nodes (Fig.
2D),-OMgp*preadsorbedwithversicanV2-Fcdidnot labelnodes
Figure2. -OMgp* detected versican V2 at CNS nodes of Ranvier.A–C, Optic nerve sections
of WT, OMgp-null, and versican V0/V2-null mice stained with -OMgp* (green), anti-IV
spectrin (blue), and anti-Kv1.2 (red). Scale bar, 5m. D, E, -OMgp* was preadsorbed with
OMgp-Fc (D) or versican V2-Fc (E) before being incubatedwithWT spinal cord sections. Arrow-
heads indicate nodes of Ranvier. Scale bars, 5m. F, Node length plotted as a function of axon
diameter in WT and OMgp-null optic nerves. G, Electron micrographs of optic nerves from
100-d-oldwild-type andOMgpnull (/)mice. Toppanels showcross sections ofmyelinated
4
axons in the optic nerves. Lower panels show single nodes of Ranvier from longitudinal sections
of optic nerves. The nodal gap is defined by the two arrows above each axon. Scale bars: top, 1
m; bottom, 0.5m.
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(Fig. 2E). Together, these results demonstrate that previous reports of
OMgp at nodes of Ranvier actually detected versicanV2.
OMgp is not enriched at CNS nodes, and its absence does not
affect paranodes or nodes
To determine the correct localization of OMgp, we tested three
commercially available anti-OMgp antibodies. Among these, only
one, a goat anti-mouse OMgp antibody, showed specificity against
OMgp (Fig. 3A,B). This antibody strongly immunolabeled wild-
type spinal cords, but notOMgp-null tissues (Fig. 3D). In contrast
to the CNS, immunostaining of wild-type and OMgp-null sciatic
nerves with the anti-OMgp antibody showed only background sig-
nals (data not shown). Similarly, Western blot analysis detected no
OMgp in sciaticnerve extracts (Fig. 3C), indicating thatOMgp isnot
expressed in the PNS, which is in contrast to previous reports
using -OMgp* (Apostolski et al., 1994; Huang et al., 2005). When
we closely examined CNS nodes in tissue sections labeled with the
goat anti-mouse OMgp antibody, we did
not detect any enrichment of OMgp (Fig.
3E). These findings indicate that OMgp is
expressed in the CNS but is not accumu-
lated at CNS nodes of Ranvier.
In addition to its nodal localization,
OMgpwas reportedpreviously tobe impor-
tant for proper nodal and paranodal struc-
ture, as well as limiting collateral sprouting
fromCNSnodes.However,ourobservation
thatOMgpisnot locatedatnodesprompted
us to reexamine CNS nodes and paranodes
in OMgp-null mice.We found that OMgp-
null tissues showed normal shapes of para-
nodal Caspr staining (Fig. 3E) in contrast to
the diffuse or ectopically clustered pattern
previously described (Huang et al., 2005).
Furthermore, when we measured nodal
length and the axon diameters in optic
nerves using immunofluorescence micros-
copy, we observed no significant difference
between wild-type and OMgp-null mice
(Fig. 2F), which is also different from what
hasbeen reported (Huanget al., 2005;Nie et
al., 2006). We found the average nodal
lengths to be 0.71  0.01 and 0.73  0.01
( p  0.09) for wild-type and OMgp-null
nerves, respectively. The average ratios of
nodal length to axon diameter were 1.01
0.02 in wild-type mice and 1.05  0.02 in
OMgp-null mice ( p  0.11). Finally, in
both wild-type and OMgp-null optic
nerves, we found no axonal sprouting at
nodes of Ranvier (Fig. 3E); however, the
complexityandheterogeneityof thenumer-
ous collaterals in the spinal cordprecluded a
robust statistical analysis (data not shown).
To further confirmour immunostaining re-
sults, we performed electronmicroscopy on
opticnerves fromwild-typeandOMgp-null
mice (Fig. 2G). In these experiments, we
foundnode lengths of 0.72 0.03m(n
30) and 0.71 0.03m(n 29) in theWT
and OMgp-null mice, respectively (SEM,
p 0.81). Furthermore, we did not observe
a single instanceofnodal sprouting inOMgp-
nullmice.Together,our results support theconclusion thatOMgp is
not required for the integrity of nodal or paranodal structure.
Althoughwedidnotobserveanyalteration innodal structure,we
nevertheless performed a rotarod test to assay motor function in
OMgp-nullmice. The average latencies to fall were 150 14.5 s and
130  9.5 s in OMgp-null (n  9) and wild-type (n  10) mice,
respectively. However, these differences were not statistically signif-
icant (SEM, p 0.28). Importantly, OMgp-null mice also show
no defects in open field locomotion, forepaw preference, or grid
walk behavioral performance tests (Ji et al., 2008; Lee et al., 2010).
These results are consistent with the idea that nodes of Ranvier are
intact and function to permit normal action potential conduction.
OMgp is expressed in white matter after the onset of
myelination and localizes outside compact myelin
Todetermine the localizationand temporal expressionofOMgp,we
immunostained optic nerves duringmyelination. At postnatal day 6
Figure3. Aspecificanti-OMgpantibodydetectednoaccumulationofOMgpatCNSnodesofRanvier.A,MediacollectedfromCOS-7cell
cultures expressing palmitoylated EGFP (GFP), Fc, OMgp-Fc, brevican-Fc, and versican V2-Fc were applied to nitrocellulose membranes
onefold (1) or twofold (2) concentratedandprobedwithagoat anti-OMgpantibodyor anti-humanFcantibody.B, Immunoblotting
of brainmembranehomogenates (hom; 75g) and cytosolic fractions (sup; 20g)made fromWT,OMgp-null, and versicanV0/V2-null
brains with or without chondroitinase ABC treatment (Ch’ase/). Blots were probed with goat anti-OMgp, stripped, and reprobed
using anti-versican V2 antibodies. C, Western blotting ofwild-type () and OMgp-null () brainmembrane homogenates (Br; 10g)
andopticnerve (ON;10g)andsciaticnerve (20g)extractswithanti-MBPandgoatanti-OMgp.D,WTandOMgp-null spinal cord cross
sections stained with goat anti-OMgp. E, WT and OMgp-null spinal cord longitudinal sections immunostained with goat anti-OMgp
(green), anti-Caspr (red), and anti-IV spectrin (blue). Arrowheads indicate nodes. Scale bars, 10m.
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(P6), very littleOMgpstainingwasobserved, and itwasnot localized
to the surface of actively myelinating oligodendrocytes (Fig. 4A).
However, inP8,P10, andadultopticnerves,OMgpstainingcouldbe
detected in a relatively dispersed pattern that did not completely
colocalize withMBP (Fig. 4B–D). Finally, when we examined cross
sections of spinal cords, we found that OMgp was located
outside compact myelin and decorated the surface of myelin-
ated axons (Fig. 4F).
Discussion
Two previous studies reported that OMgp is localized at nodes of
Ranvier in both the CNS and PNS and concluded that it plays dis-
tinct roles in formationandstabilizationofCNSnodes (Huanget al.,
2005; Nie et al., 2006). However, the data presented here strongly
argue against a role for OMgp at nodes. In both previous reports,
nodal OMgp localization was shown by immunostaining using
-OMgp*.We showed that -OMgp* strongly reacts with versican
V2 but only weakly with OMgp. Nodal staining by -OMgp* was
produced by its reactivity against versican V2, but not OMgp. This
was clearly shown by (1) immunostaining of mutant tissues, (2)
immunoadsorption tests, and (3) a specific anti-OMgp antibody,
which did not label nodes.
-OMgp* was originally generated usingOMgp isolated from
human CNS tissues through phospholipase C treatment and
PNA affinity chromatography, which purifies Gal(1–3)GalNAc
residue-bearing glycoproteins (Mikol and Stefansson, 1988;
Mikol et al., 1990). It is unlikely that the cross-reactivity can be
explained simply by a common epitope found in both versican
and OMgp, since preadsorption of -OMgp* with OMgp-Fc fu-
sion proteins did not block nodal labeling. In a different study,
purification of PNA-binding glycoproteins from spinal cords
identifiedOMgp and theN-terminal fragment of versican (Apos-
tolski et al., 1994). Furthermore, all the proteoglycan isoforms of
versican interact with PNA (Dutt et al., 2006). Therefore, it is
likely that the original purification of OMgp by phospholipase C
treatment andPNAaffinity purification resulted in copurificationof
versican.Chondroitinase treatment is required todetect themajority
of full-length versican bearing chondroitin sulfate side chains in
SDS-PAGE (Schmalfeldt et al., 1998). Even the core glycoprotein of
versican V2migrates at an apparent molecular weight of400,000.
Thus, if full-length versican had been copurified, it might have
evaded detectionwhen the purity ofOMgpwas assessed. The results
presentedhere should serve as a cautionary talewhenusing antibod-
ies and emphasize the need for careful and appropriate control ex-
periments (Rhodes and Trimmer, 2006).
Previous reports indicated that OMgp-null and OMgp mutant
micehavenodal andparanodal defects (Huanget al., 2005;Nie et al.,
2006). SincenodeofRanvier formationdependsonmyelinationand
neuron–glia interactions, it is possible that the nodal defects were
due to alteredmyelination or disrupted paranodal junctions, rather
than the absence of OMgp at nodes. However, we were unable to
detect any nodal or paranodal abnormalities by both immunofluo-
rescence and electron microscopy, suggesting that myelination and
Figure4. OMgp is expressedduringmyelinationand localizesoutside compactmyelin.A–E, Immunostainingofwild-typeP6 (A), P8 (B), P10 (C), andadult (D) andOMgp-null P35 (E) optic nerves
using goat anti-OMgp (red), anti-MBP (green), and anti-neurofilament M (NFM). Scale bars, 10m. F, Immunostaining of adult wild-type spinal cord cross sections using goat anti-OMgp (red),
anti-MBP (green), and anti-NFM (blue). The dotted line indicates the outer surface of the compact myelin. Scale bar, 1m.
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neuron–glia interactions are normal in OMgp-null mice. Further-
more, OMgp-null mice have a normal lifespan and no apparent
behavioral abnormalities: they have normal gaits and are fecund
[data not shown and Ji et al. (2008)]. Disruptions in myelination,
node, or paranode assembly would be expected to cause an overt
behavioral phenotype, similar to the paranodal or dysmyelinating
mutants previously described (Poliak and Peles, 2003).
This work not only revealed the nonspecific cross-reactivity of
-OMgp*, but also showed the correct expression and localiza-
tion of OMgp in white matter by using a specific antibody. We
found that OMgp does not localize to the surface of myelinating
oligodendrocytes at the early onset of myelination in optic
nerves, but instead increases with myelination. In adult mice,
OMgp localizes outside compact myelin and surrounds myelin-
ated axons, suggesting that OMgp is not a compact myelin com-
ponent, which is consistent with early biochemical observations
(Mikol and Stefansson, 1988). However, our results do not show
whether OMgp is expressed as a GPI-anchored form on the glial
membrane or is released from the GPI moiety (from neurons or
glia) and then becomes associated with the glial membrane. While
the formofOMgpreleased fromitsGPImoietyhasbeenobserved in
tissue homogenates and oligodendrocyte cultures (Mikol and Ste-
fansson, 1988; Nie et al., 2006; Gil et al., 2010) (Fig. 3B), the exact
functional significance remains obscure. This same antibody was
alsoused ina recent studydescribing the expressionanddistribution
ofOMgp indifferent regionsof thedevelopingmouse telencephalon
(Gil et al., 2010). Rather than a role in myelination, these authors
found that thalamocortical axons innervating the barrel cortex of
OMgp-null mice are much less restricted to layer IV cortical neu-
rons. Thus, OMgp may play roles in restricting appropriate axon
targeting in the developing cortex.
In conclusion, contrary to previous reports, we have shown here
thatOMgp isnot expressed in thePNS,OMgp isnot a componentof
the CNS nodal ECM, OMgp is not essential for node or paranode
structure, and OMgp is not a compact myelin protein. Although
OMgp’s role in injury and nervous system regeneration has been
demonstrated (Atwal et al., 2008;Giger et al., 2008; Ji et al., 2008), the
findings presented here show thatmuchwork remains to be done to
understand the normal function of OMgp in the CNS.
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